We are turning complex biological data into actionable insights, combining blood-based biomarkers and artificial intelligence for precision psychiatry.
Personalized Mental Health Care.
In today's rapidly evolving landscape of mental health treatment, the approach to personalized care is more crucial than ever. At Ketim Therapeutics, we understand that mental health is not a one-size-fits-all journey. By harnessing innovative methodologies and cutting-edge research, we tailor interventions to meet the unique needs of each individual. Our personalized mental health treatment prioritises individual histories, preferences, and biological markers, creating a comprehensive and effective therapeutic experience. Embrace a path to mental well-being that acknowledges your distinct story, empowering you to thrive in every facet of life.
Our Approach
We access ethically sourced patient data from diverse cohorts and apply advanced curation techniques to ensure accuracy and depth. By enriching this data with molecular, clinical, and AI-driven insights, we generate deep multimodal datasets that power our biomarker discovery and validation pipeline—bringing precision and reliability to mental health diagnostics and treatment development.
Multimodal Patient Data
Biomarker Validation and Qualification
Biomarker validation is the cornerstone of translating discovery into real-world clinical impact. At Ketim, we rigorously test and refine biomarkers through extensive validation studies, ensuring their accuracy, reproducibility, and clinical relevance. Our qualification process further establishes their utility for diagnostics, treatment response monitoring, and clinical trial optimization—paving the way for precision mental health care.
Integrate Biomarkers with Rich Clinical Data
We integrate biomarker data with clinical records and validated rating scales to build a rich, curated database powered by advanced AI and machine learning. This seamless fusion of molecular and patient-level insights enables precise risk prediction, personalized treatment strategies, and optimised clinical trial design—advancing the future of precision psychiatry.
AI-Driven Proprietary Database
Our AI-driven proprietary database is revolutionizing biomarker discovery, drug development, and diagnostics in mental health. By integrating multimodal patient data with advanced machine learning, we uncover novel biomarkers, accelerate drug discovery, and refine treatment strategies. This dynamic platform not only enhances precision diagnostics but also optimises clinical trials, de-risking drug development and bringing targeted therapies to patients faster.